IL-WEBER
Weber Inc . (“Weber” or “the Company”) today announced it has established 1952 Ventures LLC , a new subsidiary that will serve as an accelerator of new growth platforms and brand extensions for Weber in the areas of product, technologies, and partnerships. Troy Shay, Chief Commercial Officer of Weber Inc., has been appointed Chief Executive Officer of 1952 Ventures LLC and Chief Growth Officer of Weber. The Company also announced five additional senior leadership appointments and promotions in its Global Operations and Americas and European Operating Segments.
Troy Shay, Chief Executive Officer, 1952 Ventures LLC and Chief Growth Officer of Weber Inc.
Since joining Weber in 2018, Mr. Shay has led the Company’s Americas business in the U.S., Canada, and Latin America. He has been instrumental in managing several strategic Weber commercial initiatives, resulting in exceptional company growth. In his new position, effective December 1, 2021, Mr. Shay will focus on future business development initiatives for Weber and is responsible for identifying and developing new platforms that expand the Company’s product and brand portfolios globally.
Beau Warren Promoted to President Weber Americas
Effective December 1, 2021, Beau Warren will serve as President Weber Americas, succeeding Mr. Shay. Mr. Warren, who joined Weber in 2019 from Fortune Brands, currently serves as Senior Vice President and General Manager of Weber’s U.S. business, which has shown substantial revenue expansion under his leadership.
Michael Jacobs Appointed Chief Operating Officer of Weber Inc.
Michael Jacobs, Chief Supply Chain Officer, has been appointed to the role of Chief Operating Officer. Mr. Jacobs joined Weber in 2014 and most recently served as Chief Supply Chain Officer, leading the Company’s multi-continent manufacturing footprint and global supply chain. In his new position, Mr. Jacobs will oversee end-to-end operations for Weber, from its innovation engine to manufacturing and its customer-facing supply chain.
Jennifer Bonuso Promoted to Senior Vice President and General Manager, Global Product of Weber Inc.
Jennifer Bonuso will serve as Senior Vice President and General Manager, Global Product. Since joining Weber in 2019 from Honeywell and Whirlpool, Mrs. Bonuso has led the creation and management of an industry-leading new product pipeline.
Hans-Jurgen Herr Appointed President Emeritus and EVP Growth Projects, Weber EMEA
Effective December 1, 2021, Hans-Jürgen Herr, currently President of Weber EMEA, will transition to President Emeritus and EVP Growth Projects as part of a planned multi-year succession process. An 18-year veteran of Weber, Mr. Herr has served as President of Weber EMEA for nine years. Through his tenure as President, he has nearly tripled Weber’s business across the region. In his new role, Mr. Herr will lead several growth projects for the Company and serve in an advisory capacity for Weber’s large and growing EMEA business.
Steffen Hahn, Ph.D., Appointed In-Coming President of Weber EMEA
Dr. Steffen Hahn, currently Senior Vice President Commercial of Weber EMEA, will succeed Mr. Herr as President of Weber EMEA, effective December 1, 2021. Dr. Hahn joined Weber in early 2020 as part of a planned succession strategy. Since joining the Company, he has significantly contributed to accelerating Weber’s growth in EMEA. Before Weber, Dr. Hahn worked across a range of successful consumer business engagements at McKinsey & Company and Procter & Gamble.
“The start of 1952 Ventures along with the appointments and promotions of several senior leaders position us for continued growth and market leadership,” said Chris Scherzinger, Chief Executive Officer of Weber. “I believe a company’s success reflects the talents of its team, and we have the best global team in the business. We’ll leverage the market-leading strength of our people, our iconic brand, and our worldwide reach to drive new growth platforms and innovative ventures with world-class execution.”
“I want to thank Troy, Beau, Mike, Jennifer, Hans, and Steffen for their leadership and commitment to our Weber team members around the world and our loyal consumers and fans. I am delighted each of them will continue to work closely with me to execute our strategic plan and take our cherished brand to new heights,” added Mr. Scherzinger.
Weber Inc., headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original charcoal grill nearly 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet and electric grills, smokers, and accessories designed to help outdoor cooking enthusiasts discover what’s possible. Earlier this year, the Company acquired June Life Inc., a smart appliance and technology company, to accelerate the development of its Weber Connect® technology and digital products. Weber offers its barbecue grills and accessories, services, and experiences to a passionate community of millions across 78 countries.
Weber Connect® is a registered trademark of Weber-Stephen Products LLC.
FORWARD-LOOKING STATEMENTS
This press release contains various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Weber’s expectations or beliefs concerning future events. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed in the section titled “Risk Factors” in our Registration Statement (Registration No. 333-257824) on Form S-1. Our future results could be affected by a variety of other factors, including uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions of the COVID-19 outbreak, the current, and uncertain future, impact of the COVID-19 outbreak on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), and cash flows and liquidity, risks relating to any unforeseen changes to or effects on liabilities, future capital expenditures, revenues, expenses, earnings, synergies, indebtedness, financial condition, losses and future prospects, the ability to realize the anticipated benefits and synergies from business acquisitions in the amounts and at the times expected, the impact of competitive conditions, the effectiveness of pricing, advertising, and promotional programs; the success of innovation, renovation and new product introductions; the recoverability of the carrying value of goodwill and other intangibles, the success of productivity improvements and business transitions, commodity and energy prices, transportation costs, labor costs, disruptions or inefficiencies in supply chain, the availability of and interest rates on short-term and long-term financing, the levels of spending on systems initiatives, properties, business opportunities, integration of acquired businesses, and other general and administrative costs, changes in consumer behavior and preferences, the effect of U.S. and foreign economic conditions on items such as interest rates, statutory tax rates, currency conversion and availability, legal and regulatory factors including the impact of any product recalls; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211118005847/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
